GlassScriptPhysician profile
Katrina Ferracane
NPI 1194499889
$1,653.87
in general payments reported to CMS, 2019-2025
14 companies · $46.40 in 2025
The $46.40 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.45 · 2022: $348 · 2023: $1,143 · 2024: $105 · 2025: $46.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.36 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $254.53 | 2022-2024 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $219.09 | 2023-2024 | Caplyta |
| Supernus Pharmaceuticals, INC. | $125.13 | 2022-2023 | Qelbree |
| Axsome Therapeutics, INC. | $108.40 | 2022-2023 | Auvelity, Sunosi |
| Otsuka America Pharmaceutical, INC. | $105.55 | 2023-2025 | Rexulti |
| Corium, LLC | $85.05 | 2023 | Azstarys |
| Janssen Pharmaceuticals, INC | $81.83 | 2021-2023 | Invega Sustenna, Invega Trinza |
| Vanda Pharmaceuticals INC. | $62.02 | 2022-2023 | Hetlioz, Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $52.00 | 2022-2023 | Trintellix |
| Alkermes, INC. | $46.33 | 2022-2023 | Aristada, Lybalvi |
| Lundbeck LLC | $32.70 | 2023-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $19.43 | 2023 | Quviviq |
| Neurocrine Biosciences, INC. | $17.45 | 2023 | Ingrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Ferracane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.